Akorn has initiated a voluntary recall of various within-expiry drug products as the company has shut down operations and is unable to assure the quality of the products.
The recalled products were distributed nationwide to wholesalers, retailers, manufacturers, medical facilities, and repackagers and via the Internet to consumers. The discontinuation of the Company’s Quality program means that it is unable to support or guarantee that the medications will meet all intended specifications through the labeled shelf life of the product. CAS 96-29-7 2-Butanone oxime
All NDCs and Lots of the following Akorn products have been recalled:
Further distribution or use of these recalled products should be discontinued immediately. To date, the Company has not received any reports of adverse events related to this recall.
Adverse events or quality issues should be reported to the FDA’s MedWatch Adverse Event Reporting program. Consumers with questions regarding this recall can contact Akorn at (800) 932-5676.
Akorn issues voluntary nationwide recall of various human and animal drug products within expiry due to company shutdown. News release. Akorn. Accessed April 26, 2023. https://www.prnewswire.com/news-releases/akorn-issues-voluntary-nationwide-recall-of-various-human-and-animal-drug-products-within-expiry-due-to-company-shutdown-301808215.html.
Latest News Your top articles for Saturday
Haymarket Medical Network Top Picks
Continuing Medical Education (CME/CE) Courses
Please login or register first to view this content.
liquid acrylonitrile Copyright © 2023 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.